Nociceptin/orphanin FQ (N/OFQ) induces a quasi-morphine abstinence syndrome in the rat

Psychopharmacology

Volumn 151, Issue 4, 2000, Pages 344-350

  Malin, D H ^a   Lake, J R ^a   Moon, W D ^a   Moy, D ^a   Montellano, A L ^a   Moy, E ^a   Campbell, T D ^a   Bell, M V ^a   Bryant, D ^a   Harrison, L M ^b   Grandy, D K ^b  

^a UNIVERSITY OF HOUSTON CLEAR LAKE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Antiopiate peptides; Morphine; Nociceptin; Opiate abstinence syndrome; Opiate dependence; Orphanin

Indexed keywords

MORPHINE; NOCICEPTIN;

ABSTINENCE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVOIDANCE BEHAVIOR; CORRELATION FUNCTION; DRUG EFFECT; MALE; MORPHINE ADDICTION; NONHUMAN; PRIORITY JOURNAL; RAT; WITHDRAWAL SYNDROME;

ANIMALS; CLONIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MORPHINE; MORPHINE DEPENDENCE; OPIOID PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0033833169     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130000473     Document Type: Article

References (54)

1. Orphanin-FQ/nociceptin (OFQ/N) modulates the activity of suprachiasmatic nucleus neurons
2. Antagonism of clonidine to shaking behavior in morphine abstinence syndrome and to head twitches produced by serotonergic agents in the rat
3. Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a μ, δ, or κ opioid receptor type
4. Molecular cloning, tissue distribution and chromosomal localization of a novel member of the opioid receptor gene family
5. Nociceptin receptor coupling to a potassium conductance in rat locus coeruleus neurones in vitro
6. 2+ in the SH-SY5Y human neuroblastoma cell
7. Simultaneous activation of spinal antiopioid system (neuropeptide FF) and pain facilitory circuitry by stimulation of opioid receptors in rats
8. Biochemical correlates of narcotic withdrawal. 2. Effects of clonidine
9. A comparison of clonidine with morphine for antinociceptive and antiwithdrawal actions
10. cDNA cloning and regional distribution of a novel member of the opioid receptor family
11. 2 by the nociceptin receptor expressed in Chinese hamster ovary cells
12. Antisense oligonucleotides to human SQA-neuropeptide FF decrease morphine tolerance and dependence in mice
13. Measurement of the analgesic efficacy and potency of pentazocine by the D'Amour and Smith method
14. Orphanin FQ acts as a supraspinal, but not a spinal, anti-opioid peptide
15. Nociceptin (ORL-1) and μ opioid receptors mediate mitogen-activated protein kinase activation in CHO cells through a Gi-coupled signaling pathway: Evidence for distinct mechanisms of agonist-mediated desensitization
16. + (GIRK) channel
17. Molecular cloning of a novel G protein-coupled receptor related to the opiate receptor family
18. IgG from neuropeptide FF antiserum reverses morphine tolerance in the rat
19. 2+ pathway
20. Role of different brain structures in the expression of the physical morphine withdrawal syndrome
21. Cerebrospinal fluid from morphine-dependent rats precipitates opiate abstinence syndrome
22. 2-like mammalian peptide precipitates opiate-withdrawal syndrome in the rat
23. 2-like mammalian octapeptide: Possible role in opiate dependence and abstinence
24. Analog of neuropeptide FF attenuates morphine abstinence syndrome
25. Tyr-MIF-l precipitates abstinence syndrome in morphine-dependent rats
26. Nitric oxide synthesis inhibition attenuates behavioral actions of neuropeptide FF
27. Enhancement of spatial attention in nociceptin/orphanin FQ receptor-knockout mice
28. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor
29. Clonidine antagonizes body weight loss and other symptoms used to measure withdrawal in morphine pelleted rats given naloxone
30. Orphanin FQ is a functional anti-opioid peptide
31. Functional antagonism of μ-, δ-, and κ-opioid antinociception by orphanin FQ
32. ORL1, a novel member of the opioid receptor family: Cloning, functional expression and localization
33. Orphanin FQ, agonist of orphan opioid receptor ORL1, stimulates feeding in rats
34. Orphanin FQ: A neuropeptide that activates an opioid-like G protein-coupled receptor
35. A review of the role of anti-opioid peptides in morphine tolerance and dependence
36. Nociceptin/orphanin FQ microinjected into hippocampus impairs spatial learning in rats
37. + conductance by orphanin FQ/nociceptin in vasopressin-containing neurons
38. Changes in CNS neuropeptide FF-like material, pain sensitivity, and opiate dependence following chronic morphine treatment
39. Bidirectional modulatory effect of orphanin FQ in morphine-induced analgesia: Antagonism in brain and potentiation in spinal cord of the rat
40. Involvement of endogenous orphanin FQ in electroacupuncture-induced analgesia
41. Endogenous orphanin FQ: Evidence for a role in the modulation of electroacupuncture analgesia and the development of tolerance to analgesia produced by morphine and electroacupuncture
42. Effects of clonidine on withdrawal signs in the rat
43. Partial loss of tolerance liability to morphine analgesia in mice lacking the nociceptin receptor gene
44. 1) ligand, nociceptin, of inwardly rectifying K conductance in dorsal raphe nucleus neurons
45. 1 receptor ligand nociceptin on membrane properties of rat periaqueductal gray neurons in vitro
46. + channel
47. cDNA cloning of an orphan opiate receptor gene family member and its splice variant
48. Isolation of a novel cDNA encoding a putative membrane receptor with high homology to the cloned γ, δ, and κ opioid receptors
49. Nociceptin or antinociceptin: Potent spinal antinociceptive effect of orphanin FQ/nociceptin in the rat
50. Accelerated release and production of orphanin FQ in brain of chronic morphine tolerant rats
51. Interactions between the antiopiate Tyr-MIF-1 and the mu opiate morphiceptin at their respective binding sites in brain
52. Novel peptides and mechanisms of opiate tolerance